CRISPR comes a-knock-in to reprogram antibodies in vivo.
Nature biotechnology, 40(8): 1183-1184 PMID 35681058 DOI 10.1038/s41587-022-01299-x
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.